Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil
| Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
|---|---|
| Data(s) |
19/10/2012
19/10/2012
2008
|
| Resumo |
This study conducts a cost-effectiveness analysis of a childhood universal varicella vaccination program in Brazil. An age and time-dependent dynamic model was developed to estimate the incidence of varicella for 30 years. Assuming a single-dose schedule; vaccine efficacy of 85% and coverage of 80%, the program could prevent 74,422,058 cases and 2905 deaths. It would cost R$ 3,178,396,110 and save R$ 660,076,410 to the society and R$ 365,602,305 to the healthcare system. The program is cost-effective (R$ 14,749 and R$ 16,582 per life-year saved under the societal and the healthcare system`s perspective, respectively). The program`s cost-effectiveness is highly sensitive to the vaccine price and number of doses. (C) 2008 Elsevier Ltd. All rights reserved. |
| Identificador |
VACCINE, v.26, n.49, Special Issue, p.6281-6291, 2008 0264-410X http://producao.usp.br/handle/BDPI/25240 10.1016/j.vaccine.2008.07.021 |
| Idioma(s) |
eng |
| Publicador |
ELSEVIER SCI LTD |
| Relação |
Vaccine |
| Direitos |
restrictedAccess Copyright ELSEVIER SCI LTD |
| Palavras-Chave | #Varicella vaccine #Cost-effectiveness #Brazil #HERPES-ZOSTER EPIDEMIOLOGY #UNITED-STATES #HEALTHY-CHILDREN #BENEFIT-ANALYSIS #ECONOMIC EVALUATIONS #NEW-ZEALAND #PROGRAM #IMMUNIZATION #GERMANY #IMPACT #Immunology #Medicine, Research & Experimental |
| Tipo |
article original article publishedVersion |